- Strengthened balance sheet with the completion of a successful IPO
- Purchased, built, and activated BioHive-1, reportedly the 58th most powerful supercomputer in the world, to accelerate our drug discovery process
- Continued development of internal pipeline and partnership programs remain on track
- Promoted Ron Alfa M.D., Ph.D. to Senior Vice President of Research, to assume the responsibilities of outgoing Chief Scientific Officer Sharath Hegde, Ph.D. and further strengthen our commitment to inferential search
PR Newswire
SALT LAKE CITY, May 12, 2021